High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues
- 1 January 1999
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 721 (2) , 271-278
- https://doi.org/10.1016/s0378-4347(98)00475-7
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- A Sensitive and Simple High-Performance Liquid Chromatographic Method for the Determination of Doxorubicin and Its Metabolites in PlasmaTherapeutic Drug Monitoring, 1993
- Effects of Verapamil on the Acute Toxicity of Doxorubicin In VivoJNCI Journal of the National Cancer Institute, 1992
- A sensitive and reproducible HPLC assay for doxorubicin and pirarubicinJournal of Pharmaceutical and Biomedical Analysis, 1992
- Cardiac Toxicity 4 to 20 Years After Completing Anthracycline TherapyJAMA, 1991
- HPLC determination of doxorubicin, doxorubicinol and four aglycone metabolites in plasma of AIDS patientsJournal of Pharmaceutical and Biomedical Analysis, 1991
- Doxorubicin cardiotoxicity: analysis of prevailing hypothesesThe FASEB Journal, 1990
- High performance liquid chromatography determination of doxorubicin and daunorubicin in plasma using UV detection and column switchingBiomedical Chromatography, 1990
- Analysis of adriamycin and adriamycinol in micro volumes of rat plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicinCancer Chemotherapy and Pharmacology, 1981
- A comparison of the pharmacokinetics of multiple and single dose administrations of adriamycinInternational Journal of Radiation Oncology*Biology*Physics, 1979